| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |